HOME >> MEDICINE >> NEWS
Targeted nanoparticles incorporating siRNA offer promise for cancer treatment

The use of targeted nanoparticles offers promising techniques for cancer treatment. Researchers in the laboratory of Mark E. Davis at the California Institute of Technology have been using small interfering RNA (siRNA), sometimes known as silencing RNA, to "silence" specific genes that are implicated in certain malignancies. One of the primary challenges associated with this type of therapy is delivering the therapeutic agent into the body and then to the tumor in a safe and effective manner. By using targeted nanoparticles, researchers have demonstrated that systemically delivered siRNA can slow the growth of tumors in mice without eliciting the toxicities often associated with cancer therapies. The results of this research are being presented this week at the NSTI Nanotech 2007 Conference in Santa Clara, CA.

The Caltech researchers have incorporated siRNA into nanoparticles that are formed completely by self-assembly, characterized the behavior of these nanoparticles and studied their safety and efficacy in mice.

Using extensive physicochemical and biological characterization, the investigators are able to estimate the composition of individual nanoparticles and to correlate the nanoparticle structure with its biological function. This quantitative approach provides unique insights into the design of more effective nanoparticle carriers.

According to the lead author of the study, Derek W. Bartlett, "Safe and effective delivery remains perhaps the greatest impediment to the clinical realization of small interfering RNA (siRNA) in cancer therapy. Formation of siRNA nanoparticles using cyclodextrin-containing polycations is one of the most promising strategies for systemic siRNA delivery, and such nanoparticles are expected to enter Phase I clinical trials by late 2007. Our most recent work examines the impact of various dosing schedules and surface modifications on the efficacy of these siRNA nanoparticles in preclinical cancer mode
'"/>

Contact: Jami Walker
Jami.Walker@elsevier.com
314-579-3342
Elsevier Health Sciences
20-May-2007


Page: 1 2

Related medicine news :

1. Targeted, oral agent Enzastaurin shows favorable results
2. Targeted initiatives can encourage people to walk more
3. Targeted cancer drugs may work by disrupting balance of cellular signals
4. Targeted melanoma education of high risk groups improves screening
5. Targeted lymph node examination improves staging of colon cancer
6. Targeted therapy shows significant benefits over standard treatment for advanced kidney cancer
7. Targeted cancer drug combined with low-dose chemotherapy shrinks tumors, slows ovarian cancer
8. U-M researchers use nanoparticles to target brain cancer
9. Electric jolt triggers release of biomolecules, nanoparticles
10. Beyond the hype and the scare stories, how safe are nanoparticles?
11. MIT nanoparticles may help detect, treat tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2019)... ... November 15, 2019 , ... PlayCore’s Center for Outreach, ... physical activity programs (CSPAP) on December 3, 2019 at 2 p.m. EST. , ... this one-hour and 15-minute webinar will discuss the five components of the Comprehensive ...
(Date:11/14/2019)... ... 2019 , ... With Giving Tuesday on Dec. 3, 2019, ... organizations about the benefits of supporting local hospitalized veterans throughout Maryland. Created in ... people to give, collaborate and celebrate generosity before the holidays, and enables participants ...
(Date:11/14/2019)... , ... November 14, 2019 , ... BioInformatics Inc., part ... science tools market, today announced that 7 companies have been nominated for a ... in 2019. , Since 2002, the Life Science Industry Awards have recognized manufacturers of ...
(Date:11/12/2019)... ... November 12, 2019 , ... Each year, RESOLVE (The ... impacted those diagnosed with infertility. This year, Academy of Adoption and Assisted Reproduction ... at the Night of Hope Gala in New York City on November 11, ...
(Date:11/12/2019)... ... November 12, 2019 , ... The quality of study start-up ... times, extended contract negotiations and 80 percent of organizations still using spreadsheets to ... ripe for improvement. Following an overview of the challenges facing trial sponsors, this ...
Breaking Medicine News(10 mins):
(Date:11/19/2019)... BEAVERTON, Ore. (PRWEB) , ... November 19, 2019 ... ... safety and Lean manufacturing products, has released a new complementary guide to ... you need to get the most out of your floor tape, paint, and ...
(Date:11/16/2019)... ... 2019 , ... Leading med-tech firm MedShift is proud to ... site features a modern design, enhanced functionality, and streamlined access to essential information ... has expanded rapidly since its inception and we needed a digital platform that ...
(Date:11/16/2019)... ANGELES (PRWEB) , ... November 15, 2019 , ... Cosmetic ... were performed in 2018. While patients continue to undergo cosmetic procedures all throughout the ... by the doctor or the facility, anesthesia fees and the extent of the work ...
Breaking Medicine Technology:
Cached News: